{"id":239451,"date":"2026-09-10T09:38:53","date_gmt":"2026-09-10T04:08:53","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=239451"},"modified":"2026-09-15T09:54:34","modified_gmt":"2026-09-15T04:24:34","slug":"why-pfizer-ltd-share-52-week-consecutive-low-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/","title":{"rendered":"Pfizer Ltd. (PFIZER): Pfizer 52 Week Low Streak: Four-Day Breakdown Deepens"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/pfizer\/pfizer-ltd-share-price-today\">Pfizer Ltd. (PFIZER)<\/a> share price fell to a fresh 52-week low of Rs 4,045.7 today and later stood at Rs 4,060, down 0.05% from the previous close. Market cap was Rs 18,582.96 crore.<\/em><\/div>\n<div>\n<p style=\"margin-top:0!important;\">Pfizer Ltd. (PFIZER) has now set a fresh 52-week low for its fourth consecutive session, extending a repeated-breakdown pattern that has taken the stock down 11.63% across the streak. The latest trough stands at Rs 4,045.70, while the current price is Rs 4,060. The supplied data confirms the price pattern, but it does not establish any company-specific cause for the continued move.<\/p>\n<p>Against the previous close of Rs 4,062.05, the stock slipped Rs 2.05, or 0.05%, after opening at Rs 4,070.90 and touching an intraday high of Rs 4,074.95. Turnover stood at Rs 0.27 crore and market capitalisation at Rs 18,582.96 crore. For readers tracking the Pfizer 52 Week Low Streak, the key issue is not a single-day decline but the fact that the one-year low has been reset on each of the last four sessions.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#Pfizer_Ltd_52_Week_Low_Streak_Consecutive_Low_Analysis\" title=\"Pfizer Ltd. 52 Week Low Streak: Consecutive Low Analysis\">Pfizer Ltd. 52 Week Low Streak: Consecutive Low Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#What_the_Repeated_52-Week_Lows_Show\" title=\"What the Repeated 52-Week Lows Show\">What the Repeated 52-Week Lows Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#Pfizer_Ltd_PFIZER_Fundamental_Analysis\" title=\"Pfizer Ltd. (PFIZER) Fundamental Analysis\">Pfizer Ltd. (PFIZER) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#Why_Investors_Are_Watching\" title=\"Why Investors Are Watching\">Why Investors Are Watching<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#About_the_Company\" title=\"About the Company\">About the Company<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#Track_Pfizer_Ltd_on_Univest\" title=\"Track Pfizer Ltd. on Univest\">Track Pfizer Ltd. on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#Why_is_Pfizer_still_hitting_52-week_lows\" title=\"Why is Pfizer still hitting 52-week lows?\">Why is Pfizer still hitting 52-week lows?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#How_many_sessions_has_Pfizer_been_making_fresh_52-week_lows\" title=\"How many sessions has Pfizer been making fresh 52-week lows?\">How many sessions has Pfizer been making fresh 52-week lows?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#What_is_the_latest_52-week_low_for_Pfizer\" title=\"What is the latest 52-week low for Pfizer?\">What is the latest 52-week low for Pfizer?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#How_does_Pfizer_compare_with_peers_on_valuation\" title=\"How does Pfizer compare with peers on valuation?\">How does Pfizer compare with peers on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#Is_Pfizer_inexpensive_compared_with_the_sector\" title=\"Is Pfizer inexpensive compared with the sector?\">Is Pfizer inexpensive compared with the sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#What_do_Pfizers_return_ratios_show\" title=\"What do Pfizer\u2019s return ratios show?\">What do Pfizer\u2019s return ratios show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#What_should_investors_monitor_next\" title=\"What should investors monitor next?\">What should investors monitor next?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-pfizer-ltd-share-52-week-consecutive-low-2026\/#Track_Pfizer_Ltd_PFIZER_Share_Price_on_Univest\" title=\"Track Pfizer Ltd. (PFIZER) Share Price on Univest\">Track Pfizer Ltd. (PFIZER) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Pfizer_Ltd_52_Week_Low_Streak_Consecutive_Low_Analysis\"><\/span><strong>Pfizer Ltd. 52 Week Low Streak: Consecutive Low Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,060<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,062.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -2.05 (-0.05%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,070.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,074.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4,045.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.27 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 18,582.96 crore<\/td>\n<\/tr>\n<\/table>\n<p>Pfizer Ltd. (PFIZER) traded at Rs 4,060 versus the previous close of Rs 4,062.05, a fall of 0.05%. The stock opened at Rs 4,070.9, reached a high of Rs 4,074.95, touched a low of Rs 4,045.7.<\/p>\n<p>Pfizer share price today closed just below the previous close, and the move remained narrow in rupee terms, but the broader context is more important: the stock has kept marking lower one-year lows across consecutive sessions. The latest close of Rs 4,060 is only marginally below the previous close of Rs 4,062.05, yet it sits at the lower end of the ongoing Pfizer 52 Week Low Streak and confirms that the repeated breakdown has not yet been arrested. The day\u2019s open at Rs 4,070.90 and high of Rs 4,074.95 show that the stock did not move far away from the lower band of the session.<\/p>\n<p>The intraday low of Rs 4,045.70 matched the fresh 52-week low, which makes the close especially relevant for short-term tracking. In practical terms, the stock finished only Rs 14.30 above the day\u2019s low, suggesting that the session ended close to the weakest point of the day. Turnover of Rs 0.27 crore indicates a small traded value for the session, while the market capitalisation of Rs 18,582.96 crore places Pfizer in a sizeable listed-company bracket. For a reader scanning the Pfizer Share Price Today move, the more useful signal is the back-to-back yearly low pattern rather than the day\u2019s modest percentage change.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Lows_Show\"><\/span><strong>What the Repeated 52-Week Lows Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Pfizer 52 Week Low Streak is now the central story because it shows persistence rather than a one-off break below a support zone. Across four consecutive sessions, the stock has printed a new yearly low each day, and the cumulative decline of 11.63% is the clearest measure of how far the pattern has extended. That cumulative move matters more than the latest daily change because it captures the full streak, not only the most recent close. The same sequence also indicates that the stock has not yet found a lower band that attracts stable pricing.<\/p>\n<p>The current 52-week low of Rs 4,045.70 is the latest point in that sequence, and the repeated resets mean the prior low from the earlier session has already been overtaken. On that basis, the market has moved from a single-day break to a multi-session weakness pattern. The supplied data confirms the continued price deterioration, but it does not confirm a fresh company-specific event, operational development or sector-wide trigger behind it. For the Pfizer 52 Week Low Streak, that distinction is important: the chart pattern is real, while the cause remains unconfirmed in the available data.<\/p>\n<p>Read another way, the stock is not merely drifting lower inside a range; it is creating a new one-year trough on each session of the streak. That is why investors following Pfizer New One Year Low headlines often focus on whether the sequence is lengthening, whether the next session prints yet another fresh low, and whether the price begins to stabilise above the latest trough.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pfizer_Ltd_PFIZER_Fundamental_Analysis\"><\/span><strong>Pfizer Ltd. (PFIZER) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 18,582.96 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.28x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.22x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.39%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 160.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 963.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.85%<\/td>\n<\/tr>\n<\/table>\n<p>Pfizer Ltd. (PFIZER) fundamental metrics show P\/E 25.28x, P\/B 4.22x, ROE 17.16%, ROCE 23.39%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Pfizer Ltd. has a market capitalisation of Rs 18582.96 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 25.28x, P\/B at 4.22x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.16% and ROCE of 23.39%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 160.7, book value per share of Rs 963.41, dividend yield of 1.85%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 33.2x, median ROE of 11.61%, median ROCE of 13.18%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.28x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">33.2x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.29x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.34x to 693.7x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.22x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.39%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.18%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 18,582.96 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 692.38 crore<\/td>\n<\/tr>\n<\/table>\n<p>Pfizer Ltd. (PFIZER) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Pfizer Ltd. (PFIZER) has a P\/E ratio of 25.28x, which is below the benchmark median of 33.2x, a difference of -23.86%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Pfizer Ltd. (PFIZER) has a ROE of 17.16%, which is above the benchmark median of 11.61%, a difference of +47.8%. Pfizer Ltd. (PFIZER) has a ROCE of 23.39%, which is above the benchmark median of 13.18%, a difference of +77.47%.<\/p>\n<p>Track stocks falling to yearly lows through the <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/eris\/eris-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Eris Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ERIS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18,805.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.47<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/shilpamed\/shilpa-medicare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Shilpa Medicare Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SHILPAMED<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18,812.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">63.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.43<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/alivus\/glenmark-life-sciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Glenmark Life Sciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ALIVUS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17,005.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.61<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Astrazeneca Pharma India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ASTRAZEN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,963.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">100.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.24<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cohance\/suven-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Suven Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">COHANCE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,834.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">158.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.12<\/td>\n<\/tr>\n<\/table>\n<p>Pfizer Ltd. (PFIZER) has a P\/E ratio of 25.28x compared with the displayed peer median of 63.27x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 17.16% compares with a peer median of 18.41% across the companies shown in the table. ROCE stood at 23.39% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Pfizer Ltd. (PFIZER) has a market capitalisation of Rs 18,582.96 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching\"><\/span><strong>Why Investors Are Watching<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock has now posted a fresh 52-week low for its fourth consecutive session, making the Pfizer 52 Week Low Streak the main market event to watch.<\/li>\n<li>The cumulative decline across the streak is 11.63%, which is more informative than the latest daily move alone.<\/li>\n<li>The latest trough at Rs 4,045.70 is below the prior session\u2019s low, confirming that the one-year low keeps moving lower.<\/li>\n<li>The supplied data confirms the price pattern, but it does not establish a company-specific cause for the repeated weakness.<\/li>\n<li>Investors watching 52 Week Low Stocks may want to monitor whether the next session prints another fresh low or whether the price begins to settle above the latest trough.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_the_Company\"><\/span><strong>About the Company<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pfizer Ltd. is a listed pharmaceutical company on NSE and BSE, operating in the Pharmaceuticals &amp; Drugs industry under the broader Healthcare sector. The company\u2019s market capitalisation is Rs 18,582.96 crore, and the supplied financial metrics show earnings per share of Rs 160.7, book value of Rs 963.41 and dividend yield of 1.85%. Those numbers help place the Pfizer Share Price in a fundamental context while the market continues to mark new one-year lows.<\/p>\n<p>For readers following Pfizer Company News or broader Healthcare stock trends, the business profile matters because the current discussion is not only about a low price point but about the persistence of the Pfizer 52 Week Low Streak. The stock\u2019s current market position should be read alongside its valuation ratios, profitability measures and size within the listed healthcare universe.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Pfizer_Ltd_on_Univest\"><\/span><strong>Track Pfizer Ltd. on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Follow the Pfizer 52 Week Low Streak, the latest Pfizer Share Price Update and related Pfizer Stock Analysis on Univest for structured market coverage. Readers can also track sector context, peer comparison and other Stocks Hitting 52 Week Lows through the same stock page.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Pfizer_still_hitting_52-week_lows\"><\/span><strong>Why is Pfizer still hitting 52-week lows?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that Pfizer has made fresh one-year lows on four consecutive sessions, but it does not establish a company-specific cause. The article can therefore explain the pattern, not the trigger.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_many_sessions_has_Pfizer_been_making_fresh_52-week_lows\"><\/span><strong>How many sessions has Pfizer been making fresh 52-week lows?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer has now set a fresh 52-week low for its fourth consecutive session. That is the defining feature of the current Pfizer 52 Week Low Streak. The stock moved -0.05% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_52-week_low_for_Pfizer\"><\/span><strong>What is the latest 52-week low for Pfizer?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest 52-week low supplied is Rs 4,045.70. The current price of Rs 4,060 is only slightly above that trough, showing how close the close remained to the day\u2019s weakest point.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Pfizer_compare_with_peers_on_valuation\"><\/span><strong>How does Pfizer compare with peers on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer\u2019s P\/E of 25.28 is below the industry median of 33.2, while its P\/B of 4.22 is above the median of 3.04. That makes the valuation mixed rather than uniformly cheap or expensive.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Pfizer_inexpensive_compared_with_the_sector\"><\/span><strong>Is Pfizer inexpensive compared with the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> On earnings, Pfizer trades below the sector median P\/E. On book value, it trades above the sector median P\/B. So the valuation picture is balanced, and the price decline is not explained by one simple ratio.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Pfizers_return_ratios_show\"><\/span><strong>What do Pfizer\u2019s return ratios show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer\u2019s ROE is 17.16% and ROCE is 23.39%, both above the supplied sector medians. That indicates solid return metrics in the comparison set, even though the share price remains under pressure.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next\"><\/span><strong>What should investors monitor next?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should watch whether the next session produces another fresh 52-week low or whether the price stabilises above Rs 4,045.70. The repeat-low pattern is the main signal in the current Pfizer 52 Week Low Streak.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Pfizer_Ltd_PFIZER_Share_Price_on_Univest\"><\/span><strong>Track Pfizer Ltd. (PFIZER) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/pfizer\/pfizer-ltd-share-price-today\">Pfizer Ltd. (PFIZER) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-low lists and related market analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Ltd. Share Price hits a new 52-week low at Rs 4,060, marking a 0.05% decline today. Market cap stands at Rs 18,582.96 crore.<\/p>\n","protected":false},"author":29,"featured_media":245497,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-239451","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["245497"],"rank_math_title":["Pfizer 52 Week Low Streak: Four-Day Breakdown Deepens"],"rank_math_description":["Pfizer 52 Week Low Streak extends to a fourth straight session, with the stock down 11.63% across the streak and no company-specific cause confirmed."],"rank_math_focus_keyword":["Pfizer 52 Week Low Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Pfizer_Ltd_PFIZER_Pfizer_52_Week_Low_Streak_Four_Day_Breakdown_Deepens_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/239451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=239451"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/239451\/revisions"}],"predecessor-version":[{"id":245498,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/239451\/revisions\/245498"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/245497"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=239451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=239451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=239451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}